Ken Burns Explores America’s Inaction During the Holocaust
By Joseph Berger,
The New York Times
| 09. 01. 2022
Photo of Memorial at Yad Vashem Holocaust
Museum by Eelco Böhtlingk on Unsplash
A new documentary about the Holocaust opens with photos of perhaps the most familiar faces from that dark chapter of history: those of Anne Frank and her family, whose story has been read or seen by millions around the world.
So why would a six-hour film that offers fresh illuminations about America’s response to the Holocaust begin with such well-worn images? The answer is likely to surprise even those who know all about the arrest and eventual deaths of Anne, her sister and their mother. Their deaths, the documentary argues, were also a stain on the United States and the foundational myth of its benevolent open door for “huddled masses” of immigrants and refugees.
As recounted in “The U.S. and the Holocaust,” Ken Burns’s latest deep dive into America’s past, Otto Frank tried desperately to seek sanctuary in the U.S. for his family “only to find,” the narration says, “like countless others fleeing Nazism, that Americans did not want to let them in.” Seeing no...
Related Articles
By Rob Stein, NPR [cites CGS' Katie Hasson] | 08.06.2025
A Chinese scientist horrified the world in 2018 when he revealed he had secretly engineered the birth of the world's first gene-edited babies.
His work was reviled as reckless and unethical because, among other reasons, gene-editing was so new...
By John H. Evans, Craig Callender, Neal K. Devaraj, Farren J. Isaacs, and Gregory E. Kaebnick, Issues in Science and Technology | 07.04.2025
The controversy around a ban on “mirror life” should lead to a more nuanced public conversation about how to manage the benefits and risks of precursor biotechnologies.
About five years ago, the five of us formed a discussion group to...
By Geoffrey A. Fowler, The Washington Post | 07.17.2025
Nearly 2 million people protected their privacy by deleting their DNA from 23andMe after it declared bankruptcy in March. Now it’s back with the same person in charge — and I still don’t trust it.
Nor do the attorneys general...
By Angus Liu, Fierce Pharma | 07.22.2025
A brief skirmish between Sarepta Therapeutics and the FDA has ended before escalating into a full-on regulatory clash, as the company has bowed to the agency’s demand.
In a surprising reversal, Sarepta on Monday said it will pause all shipments...